Stada Group
Lavinia Cristina Hanganu has a diverse work experience that spans multiple industries and roles. Lavinia Cristina is currently working at STADA Group as a Global Supply Chain Lead, where they are responsible for ensuring product availability and managing supply chain constraints. Prior to this, Lavinia held the position of Global Supply Planner at STADA Group.
Before joining STADA Group, Lavinia worked at Pfizer as a Senior Supply Chain Planner. In this role, they contributed to project completion, developed inventory targets, and informed AMP Supply Planners of market dynamics.
Lavinia also has experience in demand and supply management at Unilever, where they served as a Demand & Supply Manager. Lavinia Cristina'sresponsibilities included developing demand planning processes, identifying availability risks and opportunities, and enhancing process KPIs.
Additionally, Lavinia has worked as a Service Administrator at Honeywell and as a Procurement Specialist at Hewlett Packard Enterprise.
Overall, Lavinia Cristina Hanganu has demonstrated expertise in supply chain management, demand planning, and project completion throughout their work experience.
Lavinia Cristina Hanganu obtained a Bachelor's degree in Tourism and Commercial Management from Dimitrie Cantemir University between 2012 and 2015. Lavinia Cristina also holds certifications in Lean Six Sigma Green Belt from Pfizer, obtained in 2019, and as a Technician in economic activities in 2012.
This person is not in any offices
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.